BIIB Financial Facts
Income tax expense: 337MNet income: 1.03B
See Full Income Statement
Noncontrolling interests: -2.7M
Accrued expenses and other: 2.01B
See Full Balance Sheet
Biogen Idec Inc. (BIIB) Earnings
|
Expand Research on BIIB
| Next EPS Date | 4/24/24 | EPS Growth Rate | +1.8% |
|---|---|---|---|
| Average EPS % Beat Rate | +3.0% | Revenue Growth Rate | -5.7% |
| Average % Move 1-Wk after EPS | -3.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10/22/19 |  |
Q319 | $9.17 | $8.27 | +$0.90 | $3.6B | $3.54B |  |
 | | Details |
7/23/14  |
|
Q214 | $3.49 | $2.81 | +$0.68 | $2.42B | $2.14B | |
| | Details |
| 1/29/15 |
|
Q414 | $4.09 | $3.78 | +$0.31 | $2.6B | $2.64B | |
| | Details |
| 7/21/16 |
|
Q216 | $5.21 | $4.68 | +$0.53 | $2.89B | $2.79B | = | | | Details |
| 4/21/16 |
|
Q116 | $4.79 | $4.46 | +$0.33 | $2.73B | $2.75B | = | | | Details |
| 1/27/16 |
|
Q415 | $4.50 | $4.08 | +$0.42 | $2.84B | $2.71B | = | | | Details |
| 7/23/19 | |
Q219 | $9.15 | $7.53 | +$1.62 | $3.6B | $3.48B | |
| | Details |
| 7/24/18 | |
Q218 | $5.80 | $5.24 | +$0.56 | $3.36B | $3.26B | = | | | Details |
